Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.37 USD | -1.66% | +2.85% | -32.56% |
May. 31 | Piper Sandler Starts Apellis Pharmaceuticals With Neutral Rating, $46 Price Target | MT |
May. 24 | Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases | MT |
MarketScreener Editorial Features
Global markets live: Tesla, McDonald's, Western Digital, Bed Bath & Beyond, Holcim... | April 03, 2023 at 10:53 am EDT | |
OPEC ruins the party | April 03, 2023 at 09:24 am EDT | |
ANALYST RECOMMENDATIONS : Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings... | August 25, 2022 at 05:17 am EDT |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- MarketScreener Editorial Features